Abstract:Introduction: Women are at a higher risk of developing Alzheimer's disease (AD), and the decline in estrogens post-menopause is thought of as a factor increasing this risk. Estradiol (E2) is important in supporting cholinergic neuronal integrity, and cholinergic functioning may be negatively impacted following the loss of E2 post-menopause. The use of exogenous E2 has been observed to enhance cholinergically mediated cognitive performance in healthy post-menopausal women, which indicates a potentially protective mechanism. However, E2 is often co-administered with progestin or progesterone to prevent endometrial proliferation. Progesterone/progestins have previously been shown to have a detrimental effect on E2-mediated biological and cognitive effects mediated by cholinergic systems in preclinical models, therefore the present study aimed to assess whether progesterone would modify the effect of E2 to influence cognition during cholinergic blockade. Methods: Twenty participants completed 3-months of oral E2 treatment with micronized progesterone (mPRO) or with placebo (PLC) in a repeated-measures within-subjects crossover design, in which they also completed five anticholinergic challenge days per hormone treatment condition. During the challenge participants were administered low or high doses of the nicotinic cholinergic antagonist mecamylamine, the muscarinic cholinergic antagonist scopolamine, or placebo. Following drug administration participants performed cognitive tests sensitive to cholinergic tone, assessing attention, episodic memory, and working memory. Results: Significant decrements were found on some tasks when participants were taking E2+mPRO compared to E2 alone. Specifically, under more challenging task conditions and larger anticholinergic doses, participants showed poorer performance on the Critical Flicker Fusion task and the Stroop test and responded more conservatively on the N-back working memory task. Other tasks showed no differences between treatments under cholinergic blockade. Discussion: The findings show that mPRO when taken in concert with E2, was detrimental to effortful cognitive performance, in the presence of cholinergic blockade. These results are important for assessing the impact of combined postmenopausal hormone treatment on cognitive performance that is dependent on cholinergic functioning after menopause.

Estrogen Effects on High-Affinity Choline Uptake in Primary Cultures of Rat Basal Forebrain

[Effects of Estrogen in the Central Nervous System].

Differential Regulating Effect on Estrogen Receptor Αand Β Expression in Female Rat Hippocampus and Cortex Regions Between Different Types of Estrogen Regents

Ovarian Hormones Ameliorate Memory Impairment, Cholinergic Deficit, Neuronal Apoptosis and Astrogliosis in a Rat Model of Alzheimer's Disease

Effect of estradiol with or without micronized progesterone on cholinergic-related cognitive performance in postmenopausal women

Effects Of Puerarin On Cholinergic Enzymes In The Brain Of Ovariectomized Guinea Pigs

Research progress of relationship between estrogen and cognition in women

Brain-derived Estrogen: A Critical Player in Maintaining Cognitive Health of Aged Female Rats, Possibly Involving GPR30

Neuroprotective Effects of Estrogen on Beta‐Amyloid Induced Neurotoxicity in Murine Hypothalamic Cells

17β-estradiol does not have a direct effect on the function of striatal cholinergic interneurons in adult mice in vitro

Expression of Estrogen Receptor -Alpha and -Beta Immunoreactivity in the Cultured Neonatal Suprachiasmatic Nucleus: with Special Attention to GABAergic Neurons.

Does estrogen show neuroprotective effects on hypothalamic cells when induced by beta amyloid?

Expression of estrogen receptor (ER)-? and -? immunoreactivity in hippocampal cell cultures with special attention to GABAergic neurons

C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-α and the critical period hypothesis of estrogen neuroprotection

In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology

Local Estrogen Synthesis Regulates Parallel Fiber-Purkinje Cell Neurotransmission Within the Cerebellar Cortex.

Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury

Estrogens dynamically regulate neurogenesis in the dentate gyrus of adult female rats

Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides

Effects of estradiol valerate and remifemin on norepinephrine signaling in the brain of ovariectomized rats.

Estrogen Alters Hippocampal Dendritic Spine Shape and Enhances Synaptic Protein Immunoreactivity and Spatial Memory in Female Mice.